Cartesian Therapeutics (RNAC) Stock Price, News, Quotes-Moomoo

$Cartesian Therapeutics (RNAC.US)$Cartesian Therapeutics' Rare Disease Candidate Shows Long Lasting Benefit Over Argenx's Vyvgart, Analyst Initiates With Buy
Cartesian Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Murat Kalayoglu(19.9%),Seven One Eight Three Four Irrevocable Trust(17.1%), etc.
SEC announcement
13 mins ago
Cartesian Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals...

God(S) is Stonk

Mar 27 13:59

RNAC 👀

$Cartesian Therapeutics (RNAC.US)$ did no one notice springer just bought another 1.9million shares just today 👀, simply does not explain the price action point for this week at all. Eccentric !

God(S) is Stonk

Mar 26 11:19

$Cartesian Therapeutics (RNAC.US)$ FMR had a top position in Viking Therapeutics, and here in Cartesian as well. The reverse split is to allow more institutions to follow suit. If you were to read the paper closely on the pipeline, their RNA cell therapy extends to a suite of autoimmune diseases. With a production up and coming, more partnership might be announced very soon.

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data

RNAC Cartesian Therapeutics

Trade Overview

Capital Trend

News

Comments

Analysis

Analyst Rating

Price Target